Member Exclusive

Anti-cancer drug discovery flawed, researchers claim

A team from Vanderbilt University (Nashville, TN, USA) has concluded that the current primary means of testing compounds for anti-cancer activity in cells is flawed, findings that may have far-reaching effects in the field of drug discovery.

Go to the profile of Stella Bennett
May 04, 2016

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.